Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Kyoto Pharmaceutical describes new indoline derivatives

Dec. 1, 2011

Selvita describes novel pim and haspin kinase inhibitors

Dec. 1, 2011

ADOPT study compares apixaban and enoxaparin in medically ill patients

Dec. 1, 2011

Ongoing trial investigates effects of bevacizumab in neoplastic meningitis

Nov. 30, 2011

Multi-biomarker panel may monitor clinical disease activity in subjects with RA

Nov. 30, 2011

Data presented from phase I trial of OPB-31121 in advanced solid malignancies

Nov. 30, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

SK Biopharmaceuticals divulges preclinical data on SKL-A4R

Nov. 30, 2011

New inhibitor of dual specificity protein kinase TTK shows promising preclinical antitumor activity

Nov. 29, 2011

Phase III data support lixivaptan therapy in euvolemic hyponatremia

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...